Michelle A Petri, MD, MPH
In this video, Michelle A. Petri, MD, MPH, director of the Johns Hopkins Lupus Center, discusses the following:
- treatment options, including changes in treatment protocols, and a breakdown of different classes of lupus nephritis;
- what is in the pipeline for lupus nephritis, including two new FDA approved therapies;
- treatment approaches for patients at risk of developing lupus nephritis or with existing lupus nephritis and the disease classes;
- challenges in treating the different classes of lupus nephritis and the importance of early detection;
- patient populations more likely to develop lupus nephritis and the increase in deaths from lupus nephritis;
- unmet needs of patients with lupus nephritis and racial disparities in these deaths; and
- outcome expectations for patients with lupus nephritis.
Read more about